L3 - Pathology of the female reproductive tracts Flashcards
What do over 80% of women with endometrial cancer present with?
Post menopausal bleeding
Endometrium
Composed of glands in a specialised storm with a specialised blood supply
Growth, maturation and regression of all three components is co-ordinated during each menstrual cycle
Endometrial cancer
The predominant endometrial cancer arises in the glands of the endometrium
Malignant neoplasm of glandular epithelium = adenocarcinoma
Adenocarcinomas
Adenocarcinomas arising at different sites in the body have different risk factors, pathogenesis, appearances, genetic abnormalities, behaviour, prognosis and treatment
Among adenocarcinomas arising at a single site there are multiple subtypes, initially divided by different appearances and increasingly supplemented by understanding molecular genetic pathogenesis
Subtypes of endometrial adenocarcinoma by morphology
Endometrioid
Serous
Clear cell
Mixed (components of the previous 3)
Undifferentiated
Carcinosarcomas
Why the adenocarcinoma subtypes are named endometrioid, serous, clear cell
Endometrioid cancers show differentiation that resembles endometrial glands
Serous cancers were thought to resemble Fallopian tube epithelium
Clear cell cancers have clear cytoplasm
Adenocarcinoma subtypes with similar appearance and the same names occur at other sites
E.g. there is a clear cell carcinoma of the ovary
They are NOT the same disease
If a tumour has spread to other sites it can be very difficult to work out which is the site of origin and which is the site of metastasis
Demographic and histologic studies suggest was about endometrial adenocarcinoma?
That there are two types of women that get it
The two groups differ with respect to?
Cause
Age
Morphologic types of tumour
Molecular genetic abnormalities
Precursor lesions
Prognosis and treatment
Molecular pathology
The cancer genome atlas (TCGA) published an integrated genomic classification of endometrial cancer in 4 groups
Based on integrated genomic, transcriptomic and proteomic characterisation of c370 endometrial carcinomas
TCGA Endometrial cancers
- Ultramutated cancers (DNA pol epsilon mutations) 7%
- Hypermutated cancers (defective mismatch repair and micro satellite instability) 28%
- Endometrial cancers with low frequency of DNA copy number alterations 39%
- Endometrial cancers with high frequency of DNA copy number alterations 26%
Precursor lesions in endometrial adenocarcinoma
In the cerivix, we recognise a precursor lesion to invasive squamous cell carcinoma
Cervial Intra-Epithelial neoplasia (CIN)
The disease process is called dysplasia
Much less is known about precursor lesions in the endometrium
It is assumed that the common (endometrioid) form of endometrial carcinoma has its origin in a lesion called atypical hyperplasia
This is supported by temporal genetic and morphologic continuity with endometrioid endometrial adenocarcinoma
The women at risk of endometrial adenocarcinoma
Most common invasive cancer of the female genital tract in UK
4th most common cancer in women in the UK (breast, lung, colorectum)
Lifetime risk of 1 in 46
Usually arises in postmenopausal women
Peak incidence in the 55-65 y/o age group
Most common presenting feature is postmenopausal bleeding (80%)
Endometrial cancer by age
Starts properly rising above 40yrs
Peaks at 60-64
Then decreases